February 4, 2016
It was a night of learning, sharing and making connections. The 60+ people who came to the psoriasis research update at SBP on February 2 all had something in common: psoriasis has affected their lives in some way. Continue reading “Psoriasis research event at SBP brings together patients, clinicians, and scientists”
December 15, 2015
Come join us at Sanford Burnham Prebys Medical Discovery Institute (SBP) to learn about the latest research in psoriasis and psoriatic arthritis taking place in your community. The Psoriasis Research Update and Reception is jointly sponsored by SBP and the National Psoriasis Foundation. The event will take place on:
Tuesday, February 2, 2016 6:00 – 8:00 p.m. Sanford Burnham Prebys Medical Discovery Institute Building 12 Auditorium 10905 Road to the Cure San Diego, CA 92121
Take a tour of the SBP Psoriasis Research Lab and come to the reception where we will provide hors d’oeuvres and beverages.
Our guest speakers will include:
RSVP to hbuthmann@sbpdiscovery.org by January 29, 2015 to reserve your spot.
We look forward to seeing you there!
September 17, 2015
As Dr. Carl Ware and his team at Sanford Burnham Prebys Medical Discovery Institute’s (SBP) Infectious and Inflammatory Disease Center have found, not all cytokines are created equal, and one size doesn’t fit all when it comes to treating immune disease. Continue reading “Finding a cure through immunity checks and balances”
August 25, 2015
More than 23 million Americans have an autoimmune disease. And although there are more than 80 different types of autoimmune diseases, they all have three things in common:
No cure. No cure. No cure. That’s not good news. Given that I have a 1 in 12 chance of getting an autoimmune disease in my lifetime (if you are a man your chance is 1 in 20), and those chances increase with every birthday (and mine is next month), I asked SBP experts in immunology what makes them hopeful that we are on the road to better treatments for these chronic, debilitating, and sometimes deadly diseases. Below are their forward-looking answers.
August 21, 2015
Did you know that SBP has a surfing team? Not only do we have a team, but we have a winning team! Last weekend, Carl Ware, full-time immunologist and part-time surfer, led the SBP team to victory in the Luau and Legends of Surfing Invitational, a contest held in San Diego that raises funds for the UC San Diego Moores Cancer Center.
For the past 22 years the Luau has attracted some of the most respected men and women in surfing history, along with business leaders, scientists, local politicians and national celebrities, all surfing for a cure. The event has raised more than $7 million for cancer research, improved public awareness of the need for better therapies, and always creates unlimited fun for participants and spectators.
“The Luau and Legends Invitational hits both of my passions, science and surfing. I’ve been surfing in the event for about 10 years,” said Ware. “Raising money for cancer research is great, but I especially treasure surfing with my son and teammates.”
Each competitive team consists of four members and a surf legend. This year the SBP team included Carl Ware, his son Austin, Jeff Timpson, Loni Christiansen, and surf legend Tom Ortner. Austin lives in Australia and is a sports psychologist and surf coach. Jeff, who does a remarkable head stand on his board, and Loni, who surfs a stylish switch foot, are local sufers that frequent Swami’s break. Ortner is a living legend from La Jolla who surfed professionally in the 1970’s.
The SBP team raised an impressive $15,000 for the Cancer Center.
Other notable surf stars that participated in the event were Robert August and Mike Hynson. Stars of the classic surf film Endless Summer, Pat O’Connell, Robert “Wingnut” Weaver, and Rob Machado and many others.
“We won for cancer research, and now we are planning a world tour to help defeat cancer,” added Ware.
Carl Ware, PhD, is the director of SBP’s Infectious and Inflammatory Disease Center.
July 24, 2015
A new study by researchers at SBP, the National Cancer Institute, and the Chulabhorn Research Institute has found that blocking the activity of a key immune receptor, the lymphotoxin-beta receptor (LTβR), reduces the progression of liver cancer. The results, published recently in the online edition of Gut, could provide new treatment strategies for the disease, which is the third leading cause of cancer-related deaths worldwide. Continue reading “Researchers find new method to halt the advance of liver cancer”
May 14, 2015
Today, Eli Lilly and Sanford-Burnham announced a novel collaboration to discover and develop immunological therapies. The two organizations will investigate potential therapeutics using biotechnology approaches in targeting multiple immune checkpoint modulators for the treatment of immunological diseases such as lupus, Sjögren’s syndrome, inflammatory bowel disease, and other autoimmune disorders. Continue reading “Lilly and Sanford-Burnham announce collaboration to investigate immunological therapies”